晶心科 (6533.TW) 2025Q4 financial report shows operating cash flow of 433.84M TWD, clearly higher than last year, indicating flexible capital management and steady operations. It is recommended to monitor cash flow structure, revenue, and profit changes, and compare with peers. Integrating diversified data and Growin AI Value Analysis helps assess whether the cash flow increase is driving real growth, and further understand the company’s financial strength and value potential.